Twist Bioscience reports Q4 EPS (59c), consensus (69c)

5 days ago · Reports Q4 revenue $84.71M, consensus $82.66M. Total orders received grew 24% to $88.2M. “Exiting fiscal 2024, we saw another quarter of record revenue and our seventh …

CouponFollow Extension

24%
OFF

Twist Bioscience Reports Q4 EPS (59c), Consensus (69c)

6 days from now

5 days ago · Reports Q4 revenue $84.71M, consensus $82.66M. Total orders received grew 24% to $88.2M. “Exiting fiscal 2024, we saw another quarter of record revenue and our seventh …

nasdaq.com

$367
OFF

Twist Bioscience’s Strong Growth And Profitability Potential …

6 days from now

5 days ago · Twist Bioscience sees FY25 revenue $367M-$377M, consensus $373.17M Twist Bioscience reports Q4 EPS (59c), consensus (69c) Twist Bioscience sees Q1 revenue $87M, …

businessinsider.com

$367
OFF

Twist Bioscience: Strong Market Position And ... - Markets Insider

6 days from now

4 days ago · Twist Bioscience sees FY25 revenue $367M-$377M, consensus $373.17M Twist Bioscience reports Q4 EPS (59c), consensus (69c) Twist Bioscience sees Q1 revenue $87M, …

businessinsider.com

$0.70
OFF

Twist Bioscience (TWST) Reports Q4 Loss, Tops Revenue Estimates

6 days from now

5 days ago · Twist Bioscience (TWST) Reports Q4 Loss, Tops Revenue Estimates ... The current consensus EPS estimate is -$0.70 on $83.75 million in revenues for the coming quarter and …

zacks.com

$52
OFF

Twist Bioscience Price Target Lowered To $52 From $55 At Barclays

6 days from now

4 days ago · Twist Bioscience sees FY25 revenue $367M-$377M, consensus $373.17M Twist Bioscience reports Q4 EPS (59c), consensus (69c) Twist Bioscience sees Q1 revenue $87M, …

businessinsider.com

$34
OFF

Twist Bioscience: Fiscal Q4 Earnings Snapshot - Yahoo Finance

6 days from now

5 days ago · SOUTH SAN FRANCISCO, Calif. (AP) — SOUTH SAN FRANCISCO, Calif. (AP) — Twist Bioscience Corp. (TWST) on Monday reported a loss of $34.7 million in its fiscal fourth …

yahoo.com

$82.20
OFF

Twist Bioscience Corp (TWST) Q4 2024 Earnings Report Preview: …

6 days from now

Nov 16, 2024 · Twist Bioscience Corp (NASDAQ:TWST) is set to release its Q4 2024 earnings on Nov 18, 2024. The consensus estimate for Q4 2024 revenue is $82.20 million, and the …

yahoo.com

$367
OFF

Twist Bioscience Sees FY25 Revenue $367M-$377M, Consensus …

6 days from now

5 days ago · Twist Bioscience reports Q4 EPS (59c), consensus (69c) Twist Bioscience sees Q1 revenue $87M, consensus $84.27M; Options Volatility and Implied Earnings Moves Today, …

nasdaq.com

$132
OFF

Twist Bioscience | Twist Bioscience Reports Fourth Quarter And Full ...

6 days from now

Nov 22, 2021 · Twist Bioscience Reports Fourth Quarter and Full Year Fiscal 2021 Financial Results. Nov 22, 2021 . PDF Version-- Record Revenues in Fiscal 2021 of $132.3M; Increase …

twistbioscience.com

4%
OFF

New Jersey MarketBeats | US | Cushman & Wakefield

6 days from now

Oct 8, 2024 · Q3 2024 New Jersey Industrial Report In New Jersey industrial market, leasing grew by 19.4% quarter-over-quarter (QOQ), totaling 8.0 million square feet (msf) and bringing the …

cushmanwakefield.com

$367
OFF

Cautious Outlook: Unfavorable Risk/Reward Profile For Twist …

6 days from now

4 days ago · Twist Bioscience sees FY25 revenue $367M-$377M, consensus $373.17M Twist Bioscience reports Q4 EPS (59c), consensus (69c) Twist Bioscience sees Q1 revenue $87M, …

businessinsider.com

$367
OFF

Twist Bioscience Sees FY25 Revenue $367M-$377M, Consensus …

6 days from now

5 days ago · Twist Bioscience reports Q4 EPS (59c), consensus (69c) Twist Bioscience sees Q1 revenue $87M, consensus $84.27M Options Volatility and Implied Earnings Moves Today, …

businessinsider.com

FAQs about Twist Bioscience reports Q4 EPS (59c), consensus (69c) Coupon?

How did Twist Bioscience perform in fiscal 2024?

Adjusted EBITDA for the fourth quarter of fiscal 2024 was $ (17.0) million compared to $ (26.4) million for the same period of fiscal 2023 Guidance: Twist Bioscience expects fiscal year 2025 sales of $367 million – $377 million, up 17% – 20% year over year, versus a consensus of $371.42 million. ...

What happened to Twist Bioscience?

SOUTH SAN FRANCISCO, Calif. (AP) — SOUTH SAN FRANCISCO, Calif. (AP) — Twist Bioscience Corp. (TWST) on Monday reported a loss of $34.7 million in its fiscal fourth quarter. On a per-share basis, the South San Francisco, California-based company said it had a loss of 59 cents. The results exceeded Wall Street expectations. ...

What time does Twist Bioscience (Twst) hold a conference call?

Twist Bioscience Corporation (NASDAQ: TWST) Q4 2024 Earnings Conference Call November 18, 2024 8:00 AM ET Company Participants Conference Call Participants Operator Welcome to Twist Bioscience's 2024 Fourth Quarter Financial Results Conference Call. At this time, all participants are in a listen-only mode. ...

What is the target price for Twist Bioscience Corp (Twst)?

After releasing the results, Twist Bioscience Corp (NASDAQ:TWST) was down by 19% in one day. Based on the one-year price targets offered by 10 analysts, the average target price for Twist Bioscience Corp (NASDAQ:TWST) is $53.09 with a high estimate of $62 and a low estimate of $46. ...

Does Twist Bioscience have a risk/reward profile?

Despite the company’s recent performance surpassing expectations in terms of revenue and gross margin, there are ongoing concerns about the long-term prospects of the synthetic biology market and the trajectory of Twist Bioscience’s gross margins. These concerns create a risk/reward profile that is considered unfavorable. ...

Is Twist Bioscience a good stock to buy?

Additionally, while Twist Bioscience has shown strong growth in its gene and NGS tools portfolio, and the company remains relatively insulated from potential NIH budget cuts, the premium valuation of the stock compared to its peers suggests limited upside potential. ...